about
Extending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms.The vitamin E-binding protein afamin increases in maternal serum during pregnancyNeurokinin B peptide serum levels are higher in normotensive pregnant women than in preeclamptic pregnant women.Mass spectrometric profiling of cord blood serum proteomes to distinguish infants with intrauterine growth restriction from those who are small for gestational age and from control individuals.Pre-eclampsia--still a disease of theories.Gestation-specific reference intervals for comprehensive spot urinary steroid hormone metabolite analysis in normal singleton pregnancy and 6 weeks postpartum.Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.Management of diabetes in pregnancy: comparison of guidelines with current practice at Austrian and Australian obstetric centerPhase synchronization of hemodynamic variables at rest and after deep breathing measured during the course of pregnancy.Alpha-fetoprotein and its value for predicting pregnancy outcomes - a re-evaluation.Brucellosis in a refugee who migrated from Syria to Germany and lessons learnt, 2016.New approaches to obstetric hemorrhage: the postpartum hemorrhage consensus algorithm.Treating Hypertension in Pregnancy.Using critical flicker frequency in the evaluation of visual impairment in preeclamptic women.Cervical ripening and insufficiency: from biochemical and molecular studies to in vivo clinical examination.NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls.PP063. Carotid artery stiffness and elasticity in gestational diabetes.PP057. ENOSI4 and EPHX1 polymorphisms affect maternal susceptibility topreeclampsia - Analysis of five polymorphisms predisposing tocardiovascular disease in 279 caucasian and 241 african women.PP048. Carotid intima-media-thickness in the first trimester as a predictor of preeclampsia.PP049. The arterio-venous ratio of retinal vessels in the first trimester as a predictor for preeclampsia.PP044. Differential expression of trophoblast-, endothelial- and embryonic stem cell-associated transcription factors in 1st trimester, and in 3rd trimester preeclampsia and intrauterine growth restriction.PP031. The fetal cholesterol acceptor potential in cord sera of intrauterine growth restricted (IUGR) neonates.PP009. Hypoxia alters syncytiotrophoblastic microparticles (STBM)-related coagulation capacities.2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial.Impact of array comparative genomic hybridization-derived information on genetic counseling demonstrated by prenatal diagnosis of the TAR (thrombocytopenia-absent-radius) syndrome-associated microdeletion 1q21.1.[Preventive medical check-ups during pregnancy in Austria].Ovarian vein thrombosis (OVT) following invasive group A Streptococcus (iGAS) puerperal sepsis associated with expression of streptococcal pyrogenic exotoxin genes speC, speG and speJ.Serum from healthy pregnant women reduces oxidative stress in human umbilical vein endothelial cells.[The new German guideline on postpartum haemorrhage (PPH): essential aspects for coagulation and circulatory therapy].Diagnosis and treatment of peripartum bleeding.Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix.Hemodynamic evaluation in pregnancy: limitations of impedance cardiography.Altered retinal flicker response indicates microvascular dysfunction in women with preeclampsia.Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/063, March 2016).New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.L13. The routine measurement of the sFlt1/PlGF ratio allows differential diagnosis of hypertensive pregnancy disorders and has prognostic potential in preeclamptic patients.Maternal cardiovascular and endothelial function from first trimester to postpartum.Peripartum Haemorrhage: Haemostatic Aspects of the New German PPH Guideline.Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
P50
Q31054746-ECF9C94F-9FA7-4F3F-81AD-CB000CA19283Q33786230-F1F789D6-750F-4741-BCD8-2A0BA08B9582Q34278621-D02F4EC2-3656-4E94-8056-0F466B63189FQ35077156-6AF5EAAB-FE99-418D-A6AD-BF27A24F6051Q35738762-9FD5C7AA-BADB-4BF5-858E-9B5BFFC3DFF0Q36024380-135FB963-3B8C-4FC6-B6FC-B5B9CDF2AA3DQ36034800-C9C2004F-6745-4785-B43E-FA209711CC05Q36405304-103DA5E0-279B-4408-A051-E5343F33B832Q36744747-0302AEF5-B9B4-40DA-A3C2-AA78D97D7EFAQ37007776-640C21A2-F55F-45B2-BE4B-A177701D3986Q37205810-FD359743-85DC-4DF1-816B-BA6CA716725CQ38205063-C273A703-82E7-48E5-A80B-7C30AD086F9AQ38540888-35F3AD23-539B-4EC3-B064-965B40D948BCQ38908450-28634000-6BB3-4D45-BCB3-42A05CB16C30Q39993499-44FE9F62-23A6-4ED4-804B-4D7771055C17Q40017055-2C19E49B-4299-417C-9E9D-8E932DC8537AQ40803956-BCB015D3-FCD0-485D-9BF0-8E9E89286BEBQ40803970-30E11E55-212E-4CF8-8B0A-6EAA38CF3FD1Q40804030-19E01427-AC5E-4337-BA10-193A3C84C145Q40804043-DC3D22ED-3970-4FCF-A6FC-F1F559D0ED50Q40804068-30567D0C-C1ED-4B61-B568-3D930C01D0C0Q40804125-6DB210DD-EF00-42A6-8378-83BE8A762040Q40804265-64F187AE-2E99-4031-92E9-F384CC2A0483Q41277574-327A5E58-D419-443E-8A4A-4F876B271F11Q43007237-8E7F9E71-C447-4519-A0E7-089BC8068C62Q43041277-560B9577-CA62-4E26-982E-E7A4A57E9196Q43960497-9439CFD9-4D9D-43DA-B0D4-E532079BD2E2Q44048789-CC33696B-8FDF-4C45-9053-B6B4C0A3F0A2Q46307147-27DC58DB-16EB-48D7-B98C-D925F85361C6Q46335631-5A364A74-0090-4C0A-886A-F1486E779607Q46884811-11199A53-FE05-4C51-8287-21709959D357Q47801467-CE93086D-8D12-4B31-93FC-CA183EFCFAD2Q48027297-23E0FD17-DF34-48EE-AFA2-42BD368A3808Q49165436-72359C84-5A57-4F7F-9788-9DCB33E9F8C2Q52803485-8A3FFA72-2DCF-4F60-85C0-F62A3B99A1C8Q52882005-8B089E8B-03B0-45B2-896C-F1DF44025E2BQ52894397-2F6D3CFB-5039-41D1-8F6A-39EFBBE2413EQ55141206-C9FA6538-F724-48DF-A9DA-A4F678A1BC3AQ55395624-0704FE88-A74F-47FA-B128-C425BB6F2C68Q58799364-D771BA37-896B-4454-9FEA-747A6984C66A
P50
name
Dietmar Schlembach
@en
type
label
Dietmar Schlembach
@en
prefLabel
Dietmar Schlembach
@en